[1] |
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020; 579, 270−3. doi: 10.1038/s41586-020-2012-7 |
[2] |
Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol, 2021; 19, 141−54. doi: 10.1038/s41579-020-00459-7 |
[3] |
Huang DZ, Lian XJ, Song FE, et al. Clinical features of severe patients infected with 2019 novel coronavirus: a systematic review and meta-analysis. Ann Transl Med, 2020; 8, 576. doi: 10.21037/atm-20-2124 |
[4] |
Kronbichler A, Kresse D, Yoon S, et al. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. Int J Infect Dis, 2020; 98, 180−6. doi: 10.1016/j.ijid.2020.06.052 |
[5] |
Nikolai LA, Meyer CG, Kremsner PG, et al. Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible. Int J Infect Dis, 2020; 100, 112−6. doi: 10.1016/j.ijid.2020.08.076 |
[6] |
Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med, 2020; 382, 2302−15. doi: 10.1056/NEJMoa2006100 |
[7] |
Lavezzo E, Franchin E, Ciavarella C, et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature, 2020; 584, 425−9. doi: 10.1038/s41586-020-2488-1 |
[8] |
Abraha HE, Gessesse Z, Gebrecherkos T, et al. Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia. Int J Infect Dis, 2021; 105, 776−83. doi: 10.1016/j.ijid.2021.03.037 |
[9] |
Ing AJ, Cocks C, Green JP. COVID-19: in the footsteps of Ernest Shackleton. Thorax, 2020; 75, 693−4. doi: 10.1136/thoraxjnl-2020-215091 |
[10] |
Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill, 2020; 25, 2000180. |
[11] |
Sutton D, Fuchs K, D'Alton M, et al. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med, 2020; 382, 2163−4. doi: 10.1056/NEJMc2009316 |
[12] |
Cruz-Lemini M, Perez EF, De La Cruz Conty ML, et al. Obstetric outcomes of SARS-CoV-2 infection in asymptomatic pregnant women. Viruses, 2021; 13, 112. doi: 10.3390/v13010112 |
[13] |
Hcini N, Maamri F, Picone O, et al. Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study. Eur J Obstet Gynecol Reprod Biol, 2021; 257, 11−8. doi: 10.1016/j.ejogrb.2020.11.068 |
[14] |
Wong J, Abdul Aziz ABZ, Chaw L, et al. High proportion of asymptomatic and presymptomatic COVID-19 infections in air passengers to Brunei. J Travel Med, 2020; 27, taaa066. doi: 10.1093/jtm/taaa066 |
[15] |
Lytras T, Dellis G, Flountzi A, et al. High prevalence of SARS-CoV-2 infection in repatriation flights to Greece from three European countries. J Travel Med, 2020; 27, taaa054. doi: 10.1093/jtm/taaa054 |
[16] |
Ren RQ, Zhang YP, Li Q, et al. Asymptomatic SARS-CoV-2 infections among persons entering China from April 16 to October 12, 2020. JAMA, 2021; 325, 489−92. doi: 10.1001/jama.2020.23942 |
[17] |
Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med, 2020; 382, 2081−90. doi: 10.1056/NEJMoa2008457 |
[18] |
Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep, 2020; 69, 377−81. doi: 10.15585/mmwr.mm6913e1 |
[19] |
Beiting KJ, Huisingh-Scheetz M, Walker J, et al. Management and outcomes of a COVID-19 outbreak in a nursing home with predominantly Black residents. J Am Geriatr Soc, 2021; 69, 1155−65. doi: 10.1111/jgs.17126 |
[20] |
Blain H, Gamon L, Tuaillon E, et al. Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak. Age Ageing, 2021; 50, 641−8. doi: 10.1093/ageing/afab050 |
[21] |
Atalla E, Zhang RN, Shehadeh F, et al. Clinical presentation, course, and risk factors associated with mortality in a severe outbreak of COVID-19 in Rhode Island, USA, April-June 2020. Pathogens, 2020; 10, 8. doi: 10.3390/pathogens10010008 |
[22] |
Baggett TP, Keyes H, Sporn N, et al. Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston. JAMA, 2020; 323, 2191−2. doi: 10.1001/jama.2020.6887 |
[23] |
Harris BHL, Zuhair M, Di Giovannantonio M, et al. Asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a rehabilitation facility: evolution of the presence of nasopharyngeal SARS-CoV-2 and serological antibody responses. J Infect Dis, 2021; 223, 192−6. doi: 10.1093/infdis/jiaa610 |
[24] |
Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med, 2021; 174, 286−7. doi: 10.7326/L20-1280 |
[25] |
Almadhi MA, Abdulrahman A, Sharaf SA, et al. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19. Int J Infect Dis, 2021; 105, 656−61. doi: 10.1016/j.ijid.2021.02.100 |
[26] |
Marks M, Millat-Martinez P, Ouchi D, et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis, 2021; 21, 629−36. doi: 10.1016/S1473-3099(20)30985-3 |
[27] |
Stout RL, Rigatti SJ. Seroprevalence of SARS-CoV-2 antibodies in the US adult asymptomatic population as of September 30, 2020. JAMA Netw Open, 2021; 4, e211552. doi: 10.1001/jamanetworkopen.2021.1552 |
[28] |
Lei Q, Li Y, Hou HY, et al. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections. Allergy, 2021; 76, 551−61. doi: 10.1111/all.14622 |
[29] |
Matusali G, Colavita F, Lapa D, et al. SARS-CoV-2 serum neutralization assay: a traditional tool for a brand-new virus. Viruses, 2021; 13, 655. doi: 10.3390/v13040655 |
[30] |
Manenti A, Maggetti M, Casa E, et al. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples. J Med Virol, 2020; 92, 2096−104. doi: 10.1002/jmv.25986 |
[31] |
Wang PF, Liu LH, Nair MS, et al. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Emerg Microbes Infect, 2020; 9, 2091−3. doi: 10.1080/22221751.2020.1823890 |
[32] |
Choe PG, Kim KH, Kang CK, et al. Antibody responses 8 months after asymptomatic or mild SARS-CoV-2 infection. Emerg Infect Dis, 2021; 27, 928−31. doi: 10.3201/eid2703.204543 |
[33] |
Choe PG, Kang CK, Suh HJ, et al. Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection. Emerg Infect Dis, 2021; 27, 327−9. doi: 10.3201/eid2701.203515 |
[34] |
Milani GP, Dioni L, Favero C, et al. Serological follow-up of SARS-CoV-2 asymptomatic subjects. Sci Rep, 2020; 10, 20048. doi: 10.1038/s41598-020-77125-8 |
[35] |
Kato Y, Bloom NI, Sun PF, et al. Memory B-cell development after asymptomatic or mild symptomatic SARS-CoV-2 infection. J Infect Dis, 2022. |
[36] |
He JJ, Guo YF, Mao RC, et al. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. J Med Virol, 2021; 93, 820−30. doi: 10.1002/jmv.26326 |
[37] |
Byambasuren O, Cardona M, Bell K, et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. Off J Association of Med Microbiol Infect Dis Canada, 2020; 5, 223−34. |
[38] |
Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med, 2020; 17, e1003346. doi: 10.1371/journal.pmed.1003346 |
[39] |
Alene M, Yismaw L, Assemie MA, et al. Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis. PLoS One, 2021; 16, e0249090. doi: 10.1371/journal.pone.0249090 |
[40] |
Sah P, Fitzpatrick MC, Zimmer CF, et al. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proc Natl Acad Sci USA, 2021; 118, e2109229118. doi: 10.1073/pnas.2109229118 |
[41] |
Syangtan G, Bista S, Dawadi P, et al. Asymptomatic SARS-CoV-2 carriers: a systematic review and meta-analysis. Front Public Health, 2021; 8, 587374. |